Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NO-prednisolone (NCX-1015) 是一种有效刺激体内IL-10产生的化合物,是一种释放一氧化氮(NO)的Prednisolone 衍生物。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,180 | 现货 | ||
5 mg | ¥ 2,890 | 现货 | ||
10 mg | ¥ 4,360 | 现货 | ||
25 mg | ¥ 6,960 | 现货 | ||
50 mg | ¥ 9,380 | 现货 | ||
100 mg | ¥ 12,600 | 现货 | ||
500 mg | ¥ 25,300 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 3,180 | 现货 |
产品描述 | NO-prednisolone (NCX-1015) is a compound that effectively stimulates the production of IL-10 in vivo. It is a Prednisolone derivative that releases nitric oxide (NO). |
体外活性 |
NO-prednisolone (NCX-1015) demonstrates superior effectiveness compared to Prednisolone in reducing inflammation, inhibiting the generation of cytokines and chemokines, and enhancing the expression of the steroid-sensitive cell-surface marker CD163 in human peripheral blood mononuclear cells.[1] Additionally, NO-prednisolone exhibits greater potency than Prednisolone in inducing CD163 cell surface expression. This heightened efficacy of NO-prednisolone, relative to the parent molecule Prednisolone, is also observed in the inhibition of IL-1β production induced by LPS (lipopolysaccharide).[2] |
体内活性 | In vivo, NO-prednisolone (NCX-1015) potently stimulates IL-10 production, suggesting that the NO steroid induces a regulatory subset of T cells that negatively modulates intestinal inflammation. The two doses of NO-prednisolone tested, 0.5 and 5 mg/kg/day effectively attenuate the severity of the wasting syndrome, ameliorate the colitis score, and reduce the colonic myeloperoxidase (MPO) activity. NO-prednisolone administration also reduces the colonic mRNA and protein content of tumor necrosis factor-α, IL-12, and IFN-γ. NO-prednisolone also reduces the expression of inducible NO synthase and cyclooxygenase-2. In a chronic model of granulomatous tissue inflammation, administration of NCX-1015 (13.9 μmol/kg)can effectively reduce the weight of dry granulomas, while exhibiting a lower anti-angiogenic effect.[1] |
别名 | NCX-1015 |
分子量 | 539.57 |
分子式 | C29H33NO9 |
CAS No. | 327610-87-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (41.7 mM), Sonification and heating to 60℃ are recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.8533 mL | 9.2666 mL | 18.5333 mL | 46.3332 mL |
5 mM | 0.3707 mL | 1.8533 mL | 3.7067 mL | 9.2666 mL | |
10 mM | 0.1853 mL | 0.9267 mL | 1.8533 mL | 4.6333 mL | |
20 mM | 0.0927 mL | 0.4633 mL | 0.9267 mL | 2.3167 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
NO-prednisolone 327610-87-7 Immunology/Inflammation IL Receptor NCX1015 NCX 1015 NCX-1015 Inhibitor inhibitor inhibit